- Home
- CHNR vs ADXN Comparison
CHNR vs ADXN Comparison
Compare CHNR & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHNR | ADXN |
|---|---|---|
| Founded | N/A | 2002 |
| Country | China | Switzerland |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 11.1M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | CHNR | ADXN |
|---|---|---|
| Price | $4.23 | $8.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 19.1K | 7.8K |
| Earning Date | 12-12-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $198,824.00 |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.16 | $6.51 |
| 52 Week High | $8.20 | $12.05 |
Technical Indicators
Market Signals| Indicator | CHNR | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 47.77 |
| Support Level | $3.75 | $7.12 |
| Resistance Level | $4.31 | $8.49 |
| Average True Range (ATR) | 0.29 | 0.58 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 56.95 | 52.40 |
Price Performance
Historical ComparisonAbout CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.